European Journal of Cancer
Volume 46, Issue 2 , Pages 266-269, January 2010

Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: Results of a pharmacokinetic study

  • Jos J. Kitzen

      Affiliations

    • Dept. of Medical Oncology, Erasmus University Medical Center, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
    • ,
  • Christian Puozzo

      Affiliations

    • Institut de recherche Pierre Fabre, 45, place Abel-Gance, 92654 Boulogne Cedex, France
    • ,
  • Maja J. de Jonge

      Affiliations

    • Dept. of Medical Oncology, Erasmus University Medical Center, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 180610450.
    • ,
  • Maud Brandely

      Affiliations

    • Institut de recherche Pierre Fabre, 45, place Abel-Gance, 92654 Boulogne Cedex, France
    • ,
  • Jaap Verweij

      Affiliations

    • Dept. of Medical Oncology, Erasmus University Medical Center, Groene Hilledijk 301, 3075 EA Rotterdam, Netherlands

Received 23 October 2009; accepted 29 October 2009. published online 30 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00818-1

doi:10.1016/j.ejca.2009.10.031

European Journal of Cancer
Volume 46, Issue 2 , Pages 266-269, January 2010

Article Tools